PhRMA responds to Trump blueprint with its own drug-pricing proposal: Reduce payments to PBMs

PhRMA responds to Trump blueprint with its own drug-pricing proposal: Reduce payments to PBMs - The drug manufacturing industry’s main lobbying group is backing a big change to the way prescription drugs are priced, but it’s unclear how it would impact the industry’s business model.